Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06665633 · ClinicalTrials.gov registry record · Phase 1
Treatment of U.S. Veterans With Mild Traumatic Brain Injury With Hyperbaric Oxygen Therapy
A Phase 1 study, sponsored by Nova Southeastern University.
- Completed
- Registry status
- Phase 1
- Development phase
- 40
- Enrollment target
NCT06665633 is a Phase 1 study that has completed, run by Nova Southeastern University. The registered enrollment target is 40 participants.
The verdict
NCT06665633, a Phase 1 study, has completed, sponsored by Nova Southeastern University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 40 participants
- Enrollment target
Study Summary
Mild traumatic brain (mTBI) injury affects 400,000 U.S. Veterans resulting in physical, cognitive and mental health symptoms. The Department of Defense (DoD) reported 26 suicides a day from mTBI despite ongoing care for the Veterans. The purpose of this pilot research study is to evaluate the effect of treating Veterans suffering from mTBI or persistent post-concussion syndrome with hyperbaric oxygen therapy (HBOT).
Interventions
- DRUG Oxygen 100 % Gas for Inhalation
- DEVICE Hyperbaric Oxygen Therapy Chamber
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2021-09-07 |
| Est. Completion | 2025-07-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06665633
The ClinicalTrials.gov registry entry for NCT06665633 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Nova Southeastern University, which has 71 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Oxygen 100 % Gas for Inhalation is the first listed.
NCT06665633 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06665633 about?
NCT06665633 is a clinical study titled "Treatment of U.S. Veterans With Mild Traumatic Brain Injury With Hyperbaric Oxygen Therapy". Mild traumatic brain (mTBI) injury affects 400,000 U.S. Veterans resulting in physical, cognitive and mental health symptoms. The Department of Defense (DoD) reported 26 suicides a day from mTBI despite ongoing care for the Veterans. The purpose of this pilot research study is to evaluate the effect...
What is the current status of trial NCT06665633?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 40 participants. The study started on 2021-09-07. Estimated completion is 2025-07-01.
What interventions are being tested in trial NCT06665633?
The interventions under investigation include: Oxygen 100 % Gas for Inhalation (DRUG), Hyperbaric Oxygen Therapy Chamber (DEVICE).
Who is sponsoring clinical trial NCT06665633?
This trial is sponsored by Nova Southeastern University, which has 71 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.